The European Neuroendocrine Tumor Society (ENETS) guidelines advocate a right hemicolectomy (RHC) only in patients with appendiceal neuroendocrine neoplasms (aNENs) at risk for N+(node positive). The risk is defined using site, size, and grading of tumor as well as mesoappendiceal or lymphovascular invasion.
Histopathological diagnosis of appendiceal neuroendocrine neoplasms: when to perform a right hemicolectomy? A systematic review and meta-analysis / Ricci, Claudio; Ingaldi, Carlo; Alberici, Laura; Brighi, Nicole; Santini, Donatella; Mosconi, Cristina; Ambrosini, Valentina; Campana, Davide; Minni, Francesco; Casadei, Riccardo. - In: ENDOCRINE. - ISSN 1559-0100. - STAMPA. - 66:3(2019), pp. 460-466. [10.1007/s12020-019-01984-z]
Histopathological diagnosis of appendiceal neuroendocrine neoplasms: when to perform a right hemicolectomy? A systematic review and meta-analysis
Ricci, Claudio;Ingaldi, Carlo;Alberici, Laura;Brighi, Nicole;Mosconi, Cristina;Ambrosini, Valentina;Campana, Davide;Minni, Francesco;Casadei, Riccardo
2019
Abstract
The European Neuroendocrine Tumor Society (ENETS) guidelines advocate a right hemicolectomy (RHC) only in patients with appendiceal neuroendocrine neoplasms (aNENs) at risk for N+(node positive). The risk is defined using site, size, and grading of tumor as well as mesoappendiceal or lymphovascular invasion.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
